Logo image of IMMU

Immunomedics Inc (IMMU) Stock Fundamental Analysis

USA - NASDAQ:IMMU -

87.86
+0.04 (+0.05%)
Last: 10/22/2020, 8:00:04 PM
87.9
+0.04 (+0.05%)
After Hours: 10/22/2020, 8:00:04 PM
No Fundamental Analysis report for IMMU not available.

Immunomedics Inc

NASDAQ:IMMU (10/22/2020, 8:00:04 PM)

After market: 87.9 +0.04 (+0.05%)

87.86

+0.04 (+0.05%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners1.27%
Ins Owner Change0%
Market Cap20.31B
Revenue(TTM)20.07M
Net Income(TTM)-353.41M
Analysts77.2
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1011.67
P/FCF N/A
P/OCF N/A
P/B 34.29
P/tB N/A
EV/EBITDA -62.5
EPS(TTM)-1.73
EYN/A
EPS(NY)-0.34
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.09
BVpS2.56
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -32.81%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -1559.24%
PM (TTM) -1760.55%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.84
Quick Ratio 12.58
Altman-Z 23.08
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y42.39%
EPS Next 2Y55.16%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y28.85%
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Immunomedics Inc / IMMU FAQ

What is the ChartMill fundamental rating of Immunomedics Inc (IMMU) stock?

ChartMill assigns a fundamental rating of 3 / 10 to IMMU.


Can you provide the valuation status for Immunomedics Inc?

ChartMill assigns a valuation rating of 0 / 10 to Immunomedics Inc (IMMU). This can be considered as Overvalued.


How profitable is Immunomedics Inc (IMMU) stock?

Immunomedics Inc (IMMU) has a profitability rating of 1 / 10.


How financially healthy is Immunomedics Inc?

The financial health rating of Immunomedics Inc (IMMU) is 7 / 10.


Can you provide the dividend sustainability for IMMU stock?

The dividend rating of Immunomedics Inc (IMMU) is 0 / 10 and the dividend payout ratio is 0%.